Central Serous Chorioretinopathy
"Central Serous Chorioretinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
| Descriptor ID |
D056833
|
| MeSH Number(s) |
C11.768.175
|
| Concept/Terms |
Central Serous Chorioretinopathy- Central Serous Chorioretinopathy
- Central Serous Chorioretinopathies
- Chorioretinopathies, Central Serous
- Chorioretinopathy, Central Serous
- Serous Chorioretinopathies, Central
- Serous Chorioretinopathy, Central
- Central Serous Retinopathy
- Central Serous Retinopathies
- Retinopathies, Central Serous
- Retinopathy, Central Serous
- Serous Retinopathies, Central
- Serous Retinopathy, Central
|
Below are MeSH descriptors whose meaning is more general than "Central Serous Chorioretinopathy".
Below are MeSH descriptors whose meaning is more specific than "Central Serous Chorioretinopathy".
This graph shows the total number of publications written about "Central Serous Chorioretinopathy" by people in this website by year, and whether "Central Serous Chorioretinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Central Serous Chorioretinopathy" by people in Profiles.
-
THE "SCOLEX" SIGN: A Distinct Hyperreflective Foci on the Wall of Serous Pigment Epithelial Detachments in Central Serous Chorioretinopathy - Micron Report Number Seven. Retina. 2026 May 01; 46(5):871-880.
-
Clinical Characteristics and Outcomes in Central Serous Chorioretinopathy With Subretinal Hyper-Reflective Material: MICRoN Report 6. Am J Ophthalmol. 2026 Jun; 286:152-162.
-
Efficacy and safety of intravitreal faricimab for choroidal neovascularization secondary to central serous chorioretinopathy - a multicentre study. Graefes Arch Clin Exp Ophthalmol. 2026 Feb; 264(2):407-416.
-
Predictors of persistent central serous chorioretinopathy: a multicenter retrospective study?- MICRoN report number four. Graefes Arch Clin Exp Ophthalmol. 2026 Jan; 264(1):73-80.
-
Clinical Characteristics and Progression of Pachychoroid Macular Atrophy in Central Serous Chorioretinopathy. Ophthalmol Retina. 2025 Oct; 9(10):984-993.
-
Therapies for Central Serous Chorioretinopathy: A Report by the American Academy of Ophthalmology. Ophthalmology. 2025 Mar; 132(3):343-353.
-
Update on the Management of Central Serous Chorioretinopathy. Int Ophthalmol Clin. 2024 Jan 01; 64(1):179-193.
-
Clinical impact of the worldwide shortage of verteporfin (Visudyne?) on ophthalmic care. Acta Ophthalmol. 2022 Nov; 100(7):e1522-e1532.
-
Central Serous Chorioretinopathy Associated With Fingolimod Treatment. J Neuroophthalmol. 2018 09; 38(3):337-338.
-
A rare association: Cushing disease and central serous chorioretinopathy. Can J Ophthalmol. 2017 Apr; 52(2):e77-e79.